Reliable Conjugation Technology for Precision Medicine
  • Home
  • The Technology
    • Next Gen ADC
    • Next Gen Radioconjugates
    • Peptide Asx Ligase (PALs)
    • Strong Science
  • Management
    • Board of Directors
    • Scientific Advisory Board
    • Scientific Leadership
  • News
  • Contact us
  • More
    • Home
    • The Technology
      • Next Gen ADC
      • Next Gen Radioconjugates
      • Peptide Asx Ligase (PALs)
      • Strong Science
    • Management
      • Board of Directors
      • Scientific Advisory Board
      • Scientific Leadership
    • News
    • Contact us
Reliable Conjugation Technology for Precision Medicine
  • Home
  • The Technology
    • Next Gen ADC
    • Next Gen Radioconjugates
    • Peptide Asx Ligase (PALs)
    • Strong Science
  • Management
    • Board of Directors
    • Scientific Advisory Board
    • Scientific Leadership
  • News
  • Contact us

Abbas El Sahili, Chief Technology Officer

•>30 scientific papers, 3 patents

•10 years experience

•Expertise in peptide ligases

•Expertise in protein engineering

Siew Pheng Lim, Chief Scientific Officer

•>16 years industry experience

•>70 scientific papers, 3 patents

•Expertise in cancer biology

•Expertise in drug discovery

Copyright © 2024 Singzyme

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept